Direct identification and susceptibility testing of Gram-negative bacilli from turbid urine samples using VITEK2

ABSTRACT

INTRODUCTION: Urinary tract infections (UTIs) are the most common infectious diseases occurring in either the community or healthcare setting. Turnaround time for urine culture is about 24 h, and antimicrobial susceptibility testing (AST) requires another 24 h. Consequently, initial antibiotic therapy is mostly empirical.

MATERIALS AND METHODS: This study was conducted at Nizam’s Institute of Medical Sciences, Hyderabad. Turbid urine samples which showed pus cells and Gram‑negative (GN) bacilli of single morphotype were included. The turbidity of the urine was adjusted to 0.5 McFarland and uploaded directly in the VITEK 2 identification (ID) GN and N‑280 panel for AST. The specimen was also inoculated on CHROMagar, and the ID and AST of the isolates from the agar plate were repeated on VITEK 2, and the results were compared.

RESULTS: Out of 844 turbid urines screened, 62 met the inclusion criteria. Escherichia coli was the most common isolate (71.9%). Complete agreement for ID was 80.7%, misidentified were 12.2%, and unidentified were 7%. Complete agreement with AST was 94.3%, very major errors 0.5%, major errors 2.2%, and minor errors 3%.

Conclusions: With a 94.3% agreement for AST and a reduced turnaround time by 24 h, the direct inoculation had a potential clinical benefit for initiating timely and appropriate antibiotic therapy for UTI.

Keywords

Complete agreement - major errors - minor errors - very major errors - VITEK 2 IDGN - VITEK 2 N280

Publication History

Received: 24 June 2017

Accepted: 13 November 2017

Article published online:
19 February 2020

• References

• 1 Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010;362:1804-13.
• 2 Graham JC, Galloway A. ACP best practice no 167: The laboratory diagnosis of urinary tract infection. J Clin Pathol 2001;54:911-9.
• 3 Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, et al. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: Results from the SMART study 2009-2010. Diagn Microbiol Infect Dis 2012;74:62-7.
• 4 Breteler KB, Rentenaar RJ, Verkaart G, Sturm PD. Performance and clinical significance of direct antimicrobial susceptibility testing on urine from hospitalized patients. Scand J Infect Dis 2011;43:771-6.
• 5 Kotwani A, Holloway K. Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis 2011;11:99.
• 6 Galar A, Yuste JR, Espinosa M, Guillén-Grima F, Hernáez-Crespo S, Leiva J, et al. Clinical and economic impact of rapid reporting of bacterial identification and antimicrobial susceptibility results of the most frequently processed specimen types. Eur J Clin Microbiol Infect Dis 2012;31:2445-52.
• 7 Washington JA, White IC, Laganiere M, Smith L. Detection of significant bacteriuria by microscopic examination of urine. Lab Med 1981;12:294-6.
• 8 Lamb VA, Dalton HP, Wilkins JR. Electrochemical method for the early detection of urinary-tract infections. Am J Clin Pathol 1976;66:91-5.
• 9 Cardona N, Rojas C, Zabalaga L. Leukocytes in urine and gram tint for the diagnosis of urinary infection. Rev Soc Boliviana Pediatr 2008;47:81-5.
• 10 Lehmann LE, Hauser S, Malinka T, Klaschik S, Weber SU, Schewe JC, et al. Rapid qualitative urinary tract infection pathogen identification by SeptiFast real-time PCR. PLoS One 2011;6:e17146.
• 11 Ferreira L, Sanchez-Juanes F, Gonzalez-Avila M, Cembrero-Fucinos D, Herrero-Hernandez A, Gonzalez-Buitrago JM, et al. Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010;48:2110-5.
• 12 Köhling HL, Bittner A, Müller KD, Buer J, Becker M, Rübben H, et al. Direct identification of bacteria in urine samples by matrix-assisted laserdesorption/ionization. Time-of-flight mass spectrometry and relevance of defensins as interfering factors. J Med Microbiol 2012;61:339-44.
• 13 Clark RB, Lewinski MA, Loeffelholz MJ, Tibbetts RJ. Cumitech31a: Verification and validation of procedures in the clinical microbiology laboratory. In: Sharp SE, editor. Coordinating. Washington, DC: ASM Press; 2009.
• 14 Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res 2014;139:945-8.
• 15 Ilki A, Bekdemir P, Ulger N, Soyletir G. Rapid reporting of urine culture results: Impact of the uro-quick screening system. New Microbiol 2010;33:147-53.
• 16 Marschal M, Wienke M, Hoering S, Autenrieth IB, Frick JS. Evaluation of 3 different rapid automated systems for diagnosis of urinary tract infections. Diagn Microbiol Infect Dis 2012;72:125-30.
• 17 Munoz-Dávila MJ, Roig M, Yagüe G, Blázquez A, Salvador C, Segovia M. Comparative evaluation of Vitek 2 identification and susceptibility testing of urinary tract pathogens directly and isolated from chromogenic media. Eur J Clin Microbiol Infect Dis 2013;32:773-80.
• 18 Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: General principles and contemporary practices. Clin Infect Dis 1998;26:973-80.
• 19 Bazzi AM, Rabaan AA, Fawarah MM, Al-Tawfiq JA. Direct identification and susceptibility testing of positive blood cultures using high speed cold centrifugation and Vitek II system. J Infect Public Health 2017;10:299-307.
• 20 Ferreira L, Vega S, Sánchez-Juanes F, González M, Herrero A, Muñiz MC, et al. Identifying bacteria using a matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometer. Comparison with routine methods used in clinical microbiology laboratories. Enferm Infecc Microbiol Clin 2010;28:492-7.